Celltrion Receives Japanese Marketing Approval for Omriclone and Eydengelt
Omriclone Becomes the First Xolair Biosimilar Approved in Japan
"Lineup Expanded to Asthma and Ophthalmic Diseases with Approval of Two New Products"
Celltrion has received marketing approval in Japan for two biosimilars: an allergy treatment and an ophthalmic treatment.
On March 27, Celltrion announced that it has obtained marketing approval from Japan’s Ministry of Health, Labour and Welfare for the omalizumab biosimilar “Omriclone” and the aflibercept biosimilar “Eydengelt.” Omriclone has been approved for all indications of the original drug, including bronchial asthma, chronic urticaria, and seasonal allergic rhinitis.
Omriclone is the first Xolair biosimilar to be approved in Japan. It has been approved in two formulations: pre-filled syringe and auto-injector. The original drug, Xolair, recorded approximately 7.6 trillion KRW in global sales last year.
Eydengelt has been approved for major ophthalmic indications such as macular degeneration and diabetic macular edema, with both vial and pre-filled syringe formulations. The original drug, Eylea, achieved global sales of about 8.5 trillion KRW.
With this approval, Celltrion has expanded its product portfolio from a focus on autoimmune diseases and oncology to now include ophthalmology and allergy treatments.
Celltrion has continued to increase its market share in Japan through its existing biosimilar products. According to pharmaceutical market research firm IQVIA, the breast cancer treatment “Herzuma” holds about a 76% market share in Japan, maintaining the top position for trastuzumab prescriptions. “Begzelma” currently has a 58% share. The autoimmune disease treatments “Remsima” and “Yuflyma” also hold 43% and 17% market shares, respectively.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
A Celltrion official stated, “We plan to further expand our product lineup in Japan through the early market entry of these newly approved products.”
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.